Market revenue in 2020 | USD 10,776.7 million |
Market revenue in 2028 | USD 23,838.7 million |
Growth rate | 10.4% (CAGR from 2020 to 2028) |
Largest segment | Injectable |
Fastest growing segment | Injectable |
Historical data covered | 2017 - 2019 |
Base year for estimation | 2020 |
Forecast period covered | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Topical, Injectable, Oral |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to atopic dermatitis drugs market will help companies and investors design strategic landscapes.
injectable was the largest segment with a revenue share of 46.3% in 2020. Horizon Databook has segmented the Global atopic dermatitis drugs market based on topical, injectable, oral covering the revenue growth of each sub-segment from 2017 to 2028.
Horizon Databook provides a detailed overview of global-level data and insights on the Global atopic dermatitis drugs market , including forecasts for subscribers. This global databook contains high-level insights into Global atopic dermatitis drugs market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account